Modern Approaches to the Management of Patients with Hyperkaliemia
Hyperkalemia is the most common electrolyte imbalance in clinical practice. Hyperkalemia can be caused by an increased intake of potassium into the body, the shift of potassium out of cells or an abnormal renal potassium excretion. This condition is associated with a high risk of death from arrhythm...
Saved in:
| Main Authors: | E. V. Reznik, A. I. Selivanov, A. R. Lutsenko, L. A. Garanina, G. N. Golukhov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2022-02-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/1370 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01) -
Impaired aldosterone response to potassium and hyperkalemia in patients receiving a renin-angiotensin-aldosterone system inhibitor
by: Miyeon Kim, et al.
Published: (2025-05-01) -
Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis
by: Rhys Williams, et al.
Published: (2024-11-01) -
Patiromer to Reduce Albuminuria Through Increased Renin Angiotensin Aldosterone System Inhibition in Patients With CKD-A Feasibility Trial
by: Frederik H. Mårup, et al.
Published: (2024-08-01) -
Duration of sodium zirconium cyclosilicate treatment and continuation of RAASi therapy after a hyperkalaemia episode
by: Charles V. Pollack Jr., et al.
Published: (2025-06-01)